Comparative analysis of the effects of dalteparin and reviparin on perioperative blood loss in patients with extracapsular hip fractures treated with intramedullary nailing
Aim To determine differences between reviparin and dalteparin treatment in patients with extracapsular hip fractures treated with intramedullary nailing and their effects on perioperative blood loss and early postoperative recovery. Methods Retrospective comparative study included 68 patients with extracapsular hip fracture who were divided into dalteparin and reviparin group. Medical records were used to obtain demographic data, laboratory parameters, haemoglobin and haematocrit levels, platelet count, mortality rate and medical complications. Results Out of total 68 patients, 31 were in reviparin and 37 in dalteparin group. Mean age of patients was 70.5 (±14.4) and 76.8 (±8.4) years in reviparin and dalteparin group, respectively (p=0.071). Median values of haemoglobin levels on the first postoperative day were lower in dalteparin group compared to reviparin group (p=0.012). On the first postoperative day haematocrit values were also lower in dalteparin than in reviparin group (p=0.015). Both groups showed an increase in platelet count on the first postoperative day, but without significant difference (p=0.084). There was no statistically significant difference in intrahospital mortality between the groups (6.4% vs. 2.7%; p=0.588). One case of pulmonary embolism was detected in the dalteparin group. Conclusion Low-molecular-weight heparin is the drug of choice in patients with hip fractures for thromboprophylaxis. Due to non-antithrombin-mediated actions, reviparin and dalteparin could have different effects on perioperative blood loss. Both dalteparin and reviparin are safe and effective agents for thromboprophylaxis in patients with proximal femur fractures.
Okoye O, Gelbard R, Inaba K, Esparza M, Belzberg H, Talving P, et al. Dalteparin versus Enoxaparin for the prevention of venous thromboembolic events in trauma patients. Eur J Trauma Emerg Surg 2014:183–9.
2
Planès A, Vochelle N, Fagola M, Bellaud M. Comparison of two low-molecular-weight heparins for the prevention of postoperative venous thromboembolism after elective hip surgery. Blood Coagul Fibrinolysis 1998:499–505.
3
Owings J, Kraut E, Battistella F, Cornelius J, Malley O, R. Timing of the occurrence of pulmonary embolism in trauma patients. Arch Surg 1997:862–7.
4
Biławicz J, Lipa M, Wielgos M. Comparison of lowmolecular-weight heparins in thromboprophylaxis of major orthopaedic surgery -randomized, prospective pilot study. Open Med 2020:1048–53.
5
Nagra N, Van Popta D, Whiteside S, Holt E. An analysis of postoperative hemoglobin levels in patients with a fractured neck of femur. Acta Orthop Traumatol Turc 2016:507–13.
6
Seong Y, Shin W, Moon N, Suh K. Timing of Hip-fracture Surgery in Elderly Patients: Literature Review and Recommendations. Hip Pelvis 2020:11–6.
7
Bisaccia M, Rinonapoli G, Meccariello L, Ripani U, Pace V, Rollo G, et al. Osteoporosis in male patients: epidemiology, clinical aspects and DEXA Scan assessment. Clin Cases Miner Bone Metab 2019:31–5.
8
Rinonapoli G, Ruggiero C, Meccariello L, Bisaccia M, Ceccarini P, Caraffa A. Osteoporosis in men: a review of an underestimated bone condition. Int J Mol Sci 2021:2105.
9
Zuckerman J. Hip fracture. N Engl J Med 1996:1519–25.
10
Li L, Bennett-Brown K, Morgan C, Dattani R. Hip fractures. Br J Hosp Med 2020:1–10.
11
Mayhew D, Mendonca V, Murthy B. A review of ASA physical status -historical perspectives and modern developments. Anaesthesia 2019:373–9.
12
Müller M, Koch P, Nzarian S, Schatzker J. The Comprehensive Classification of Fractures of Long Bones 1990.
13
Begatin J, Carević V, Begatin K. Jesu li svi niskomolekularni heparini jednaki? (Are all low molecular wight heparins the same?) [in Croatian]. Medicus 2010:191–6.
14
Miano T, Cuker A, Christie J, Martin N, Smith B, Makley A, et al. Comparative Effectiveness of enoxaparin vs dalteparin for thromboprophylaxis after traumatic injury. Chest 2018:133–42.
15
Tornetta P, Ricci M, Ostrum F, Mcqueen M, Mckee M. Rockwood and Green’s Fractures in Adults 2019.
16
David G, Umberto M, Cioancă R, F, Alfonso A, Cristina C, et al. Metabolic Shock in Elderly Pertrochanteric or Intertrochanteric Surgery. Comparison of three surgical methods. Is there a much safer? Rom J Anaesth Intensive Care 2020:17–26.
17
Lanzetti R, Caraffa A, Lupariello D, Ceccarini P, Gambaracci G, Meccariello L, et al. Comparison between locked and unlocked intramedullary nails in intertrochanteric fractures. Eur J Orthop Surg Traumatol 2018:649–58.
18
Chang H, Lu W, Kuan F, Su W, Chen P, Su P, et al. Wound drainage after proximal femoral nail antirotation (PFNA) fixation may negatively affect the patients with intertrochanteric fractures: A prospective randomized controlled trial. Injury 2021:575–81.
19
Schiavone A, Bissacia M, Inkov I, Rinonapoli G, Manni M, Rollo G, et al. Tranexamic acid in petrochanteric femoral fracture: Is it a safe drug or not. Folia Med (Plovdiv) 2018:67–78.
20
Tian S, Shen Z, Liu Y, Zhang Y, Peng A. The effect of tranexamic acid on hidden bleeding in older intertrochanteric fracture patients treated with PFNA. Injury 2018:680–4.
21
Foss N, Kristensen M, Kehlet H. Anaemia impedes functional mobility after hip fracture surgery. Age Ageing 2008:173–8.
22
Hao C, Sun M, Wang H, Zhang L, Wang. Low molecular weight heparins and their clinical aplications. Prog Mol Biol Transl Sci 2019:21–39.
23
Ronga M, Bonzini D, Valoroso M, Barbera L, Tamini G, Cherubino J, et al. Blood loss in trochanteric fractures: multivariate analysis comparing dynamic hip screw and Gamma nail. Injury 2017;(Suppl 3):44–7.
24
Racine E. Differentiation of the low-molecularweight heparins. Pharmacotherapy 2001:62–70.
25
Sanchez M, Lozano H, Velarde-Garrido D, Alarma B, Sanchez-Mayoral V, Romera O, et al. Key factors influencing clinical and functional outcomes in extracapsular proximal femur fractures: the role of early weight-bearing -one-year follow-up cohort of 495 patients. Med Glas 2021:280–6.
26
AO Principles of Fracture Management. 3 2017.
27
Dhanwal K, Dennison M, Harvey C, Cooper C. Epidemiology of hip fracture: Worldwide geographic variation. Indian J Orthop 2011:15–22.
28
Vestergaard P, Rejnmark L, Mosekilde L. Has mortality after a hip fracture increased? J Am Geriatr Soc 2007:1720–6.
The statements, opinions and data contained in the journal are solely those of the individual authors and contributors and not of the publisher and the editor(s). We stay neutral with regard to jurisdictional claims in published maps and institutional affiliations.
,
